Donaldson Company, Inc. (NYSE: DCI), a provider of filtration products and services, has acquired Solaris Biotechnology SrL.

Solaris is a designer and manufacturer of bioprocessing equipment including bio reactors, fermenters and tangential flow filtration systems used in food and beverage, biotechnology and life science sectors. The firm’s portfolio ranges from bench-top systems for R&D to pilot and commercial-scale manufacturing services.

“We are excited about Solaris’ capabilities and growth trajectory, and this acquisition is an important step on our journey towards strengthening our presence in the life sciences market,” said Tod Carpenter, chairman, president and chief executive officer of Donaldson. “With Solaris, we are well-positioned to provide more comprehensive solutions to food and beverage customers and expand our access to biopharma and other key life sciences markets. “